Airway Management of Respiratory Failure
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Tracheal Intubation Following Traumatic Injury)
CLINICAL MANAGEMENT UPDATE The Journal of TRAUMA Injury, Infection, and Critical Care Guidelines for Emergency Tracheal Intubation Immediately after Traumatic Injury C. Michael Dunham, MD, Robert D. Barraco, MD, David E. Clark, MD, Brian J. Daley, MD, Frank E. Davis III, MD, Michael A. Gibbs, MD, Thomas Knuth, MD, Peter B. Letarte, MD, Fred A. Luchette, MD, Laurel Omert, MD, Leonard J. Weireter, MD, and Charles E. Wiles III, MD for the EAST Practice Management Guidelines Work Group J Trauma. 2003;55:162–179. REFERRALS TO THE EAST WEB SITE and impaired laryngeal reflexes are nonhypercarbic hypox- Because of the large size of the guidelines, specific emia and aspiration, respectively. Airway obstruction can sections have been deleted from this article, but are available occur with cervical spine injury, severe cognitive impairment on the Eastern Association for the Surgery of Trauma (EAST) (Glasgow Coma Scale [GCS] score Յ 8), severe neck injury, Web site (www.east.org/trauma practice guidelines/Emergency severe maxillofacial injury, or smoke inhalation. Hypoventi- Tracheal Intubation Following Traumatic Injury). lation can be found with airway obstruction, cardiac arrest, severe cognitive impairment, or cervical spinal cord injury. I. STATEMENT OF THE PROBLEM Aspiration is likely to occur with cardiac arrest, severe cog- ypoxia and obstruction of the airway are linked to nitive impairment, or severe maxillofacial injury. A major preventable and potentially preventable acute trauma clinical concern with thoracic injury is the development of Hdeaths.1–4 There is substantial documentation that hyp- nonhypercarbic hypoxemia. Lung injury and nonhypercarbic oxia is common in severe brain injury and worsens neuro- hypoxemia are also potential sequelae of aspiration. -
Statement on Safe Use of Propofol 2019
Statement on Safe Use of Propofol Committee of Origin: Ambulatory Surgical Care (Approved by the ASA House of Delegates on October 27, 2004, and amended on October 23, 2019) Because sedation is a continuum, it is not always possible to predict how an individual patient will respond. Due to the potential for rapid, profound changes in sedative/anesthetic depth and the lack of antagonist medications, agents such as propofol require special attention. Even if moderate sedation is intended, patients receiving propofol should receive care consistent with that required for deep sedation. The Society believes that the involvement of an anesthesiologist in the care of every patient undergoing anesthesia is optimal. However, when this is not possible, non-anesthesia personnel who administer propofol should be qualified to rescue* patients whose level of sedation becomes deeper than initially intended and who enter, if briefly, a state of general anesthesia.** • The physician responsible for the use of sedation/anesthesia should have the education and training to manage the potential medical complications of sedation/anesthesia. The physician should be proficient in airway management, have advanced life support skills appropriate for the patient population, and understand the pharmacology of the drugs used. The physician should be physically present throughout the sedation and remain immediately available until the patient is medically discharged from the post procedure recovery area. • The practitioner administering propofol for sedation/anesthesia should, at a minimum, have the education and training to identify and manage the airway and cardiovascular changes which occur in a patient who enters a state of general anesthesia, as well as the ability to assist in the management of complications. -
Airway Management for COVID 19
Airway Management in Critically Ill COVID-19 Patients KATHERINE HELLER, MD ASSISTANT PROFESSOR UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE DEPARTMENT OF ANESTHESIOLOGY MEDICAL DIRECTOR: UWMC SICU Disclosures (none) Outline Staff safety PPE Patient factors/ timing Adjuncts for oxygenation Intubation procedure Preparation Equipment/technique Unusual situations Difficult airways Tracheostomy Emergencies Opening Questions Please navigate to pollev.com/katherinehel603 Priorities Priority #1: Staff Safety Considerations for Staff Procedural planning Appropriate PPE takes time Avoid emergencies when able Consider rounding (remotely?) on known COVID patients PPE Any airway management is an Aerosol Generating Procedure (AGP) Need respirator level protections airborne + contact/droplet N95 vs PAPR N95 PAPR Pro Pro Easy to don Comfortable Fast Protect face, neck, head Allow use of stethoscope Reusable More readily available Con Con Allows contamination of Require power source face and neck Need assistance to don Less comfortable and doff May not fit everyone Noisy Fit can change Infection Control Choose what work for you and your institution More important to have clear protocols and expectations Minimize in room staff Have equipment easily available Filter in line on circuit Infection control Barrier Devices Not recommended Additional encumbrance to intubation without proven benefit Not a replacement for PPE May actually increase risk [11] Failed airway Breach of PPE FDA revoked EUA for barrier devices in -
Intravenous Sedation and Preparing for Your Procedure
Oral and Maxillofacial Surgery Intravenous sedation and preparing for your procedure Information for patients Please ensure that you read this leaflet before you come to hospital for your operation What is sedation? Sedation is a way of using drugs (sedatives) to make you feel relaxed and sleepy during your procedure. We will give you your sedatives through an injection into a vein. Sedation is not a general anaesthetic and you will not be unconscious. You may not remember much of what happens during the procedure and directly afterwards. This is quite normal. Local anaesthetic will be given once you have been sedated. Do not drive, operate machinery or sign important documents for at least 24 hours after your procedure. You must make sure that you have a responsible adult with you who can stay in the department for a couple of hours and take you home by car or taxi. Someone must also stay with you for at least 24 hours after your procedure. Your procedure will be cancelled if you do not bring someone with you who can do this. Preparation for your procedure and what to bring with you • Patients having a procedure under sedation must follow the current fasting guidelines for general anaesthesia. You must not eat or drink for 6 hours before your procedure but you may have water up to 2 hours before. If you do eat or drink after these times your surgery will be cancelled. • Avoid alcohol for 24 hours before your procedure. • Bring with you a list of any medication or drugs you are taking. -
Femoral and Sciatic Nerve Blocks for Total Knee Replacement in an Obese Patient with a Previous History of Failed Endotracheal Intubation −A Case Report−
Anesth Pain Med 2011; 6: 270~274 ■Case Report■ Femoral and sciatic nerve blocks for total knee replacement in an obese patient with a previous history of failed endotracheal intubation −A case report− Department of Anesthesiology and Pain Medicine, School of Medicine, Catholic University of Daegu, Daegu, Korea Jong Hae Kim, Woon Seok Roh, Jin Yong Jung, Seok Young Song, Jung Eun Kim, and Baek Jin Kim Peripheral nerve block has frequently been used as an alternative are situations in which spinal or epidural anesthesia cannot be to epidural analgesia for postoperative pain control in patients conducted, such as coagulation disturbances, sepsis, local undergoing total knee replacement. However, there are few reports infection, immune deficiency, severe spinal deformity, severe demonstrating that the combination of femoral and sciatic nerve blocks (FSNBs) can provide adequate analgesia and muscle decompensated hypovolemia and shock. Moreover, factors relaxation during total knee replacement. We experienced a case associated with technically difficult neuraxial blocks influence of successful FSNBs for a total knee replacement in a 66 year-old the anesthesiologist’s decision to perform the procedure [1]. In female patient who had a previous cancelled surgery due to a failed tracheal intubation followed by a difficult mask ventilation for 50 these cases, peripheral nerve block can provide a good solution minutes, 3 days before these blocks. FSNBs were performed with for operations on a lower extremity. The combination of 50 ml of 1.5% mepivacaine because she had conditions precluding femoral and sciatic nerve blocks (FSNBs) has frequently been neuraxial blocks including a long distance from the skin to the used for postoperative pain control after total knee replacement epidural space related to a high body mass index and nonpalpable lumbar spinous processes. -
Moderate Sedation Study Guide 11-17-10
PROCEDURE RELATED SEDATION Outline I Introduction II Definitions: The 5 Levels of Sedation and Anesthesia III Emergency Procedures, Critical Care Areas and Policy Exclusions IV The Pre-Sedation Assessment V NPO: The Timing of Eating and Drinking before Sedation VI Review of Some Agents Used for Sedation VII Orders for Procedure Related Sedation VIII Environmental Requirements and Monitoring During Sedation IX Post-Procedure Monitoring and the PAR Score X Discharge Criteria and Concluding Post-Procedure Monitoring 1 PROCEDURE RELATED SEDATION Lance Brown, MD, MPH I. Introduction The purpose of this tutorial is to familiarize the reader with the Loma Linda University Medical Center Policy M-86 for Procedure Related Sedation. Procedure related sedation is used to make necessary medical procedures as comfortable as possible for patients and to facilitate the performance of necessary medical procedures by health care providers (typically physicians). It is important for health care providers performing procedure related sedation to be familiar with the pharmacologic characteristics of the agents being used, to understand the risk factors for complications related to procedure related sedation, and to individually plan the sedation for each patient. Each health care practitioner privileged to provide procedure related sedation takes responsibility for both the comfort and safety of the patients in their care. II. Definitions At Loma Linda University Medical Center, we have defined five distinct levels of sedation and anesthesia. Familiarity with the definitions of these levels of sedation is important for safely providing procedure related sedation and for complying with the policy of the Medical Center. It must be recognized, however, that sedation occurs along a continuum and that individual patients may have different degrees of sedation for a given dose and route of medication. -
Dexmedetomidine During Suprazygomatic Maxillary Nerve Block for Pediatric Cleft Palate Repair, Randomized Double-Blind Controlled Study Mohamed F
Korean J Pain 2020;33(1):81-89 https://doi.org/10.3344/kjp.2020.33.1.81 pISSN 2005-9159 eISSN 2093-0569 Original Article Dexmedetomidine during suprazygomatic maxillary nerve block for pediatric cleft palate repair, randomized double-blind controlled study Mohamed F. Mostafa1, Fatma A. Abdel Aal1, Ibrahim Hassan Ali1, Ahmed K. Ibrahim2, and Ragaa Herdan1 1Department of Anesthesia and Intensive Care, Faculty of Medicine, Assiut University, Assiut, Egypt 2Department of Public Health, Faculty of Medicine, Assiut University, Assiut, Egypt Received July 26, 2019 Revised December 3, 2019 Background: For children with cleft palates, surgeries at a young age are necessary Accepted December 3, 2019 to reduce feeding or phonation difficulties and reduce complications, especially respiratory tract infections and frequent sinusitis. We hypothesized that dexmedeto- Correspondence midine might prolong the postoperative analgesic duration when added to bupiva- Mohamed F. Mostafa caine during nerve blocks. Department of Anesthesia and Intensive Methods: Eighty patients of 1-5 years old were arbitrarily assigned to two equal Care, Assiut University Hospital, Faculty groups (forty patients each) to receive bilateral suprazygomatic maxillary nerve of Medicine, Assiut University, Assiut blocks. Group A received bilateral 0.2 mL/kg bupivacaine (0.125%; maximum vol- 71515, Egypt Tel: +20-1001123062 ume 4 mL/side). Group B received bilateral 0.2 mL/kg bupivacaine (0.125%) + 0.5 Fax: +20-88-2333327 μg/kg dexmedetomidine (maximum volume 4 mL/side). E-mail: [email protected] Results: The modified children’s hospital of Eastern Ontario pain scale score was significantly lower in group B children after 8 hours of follow-up postoperatively (P < 0.001). -
Moderate Sedation
MODERATE SEDATION A SELF STUDY GUIDE Part I Self Study Guide Part II ASA Practice Guidelines for Sedation And Analgesia by Non-Anesthesiologists Part III Sedation/Analgesia Policy 1 Introduction Diagnostic and surgical procedures are being performed in a variety of settings throughout the hospital. This self-study program has been developed to increase your awareness and reinforce your understanding of the use of moderate sedation. It includes indications/contraindications for moderate sedation, accepted medications administration guidelines, and monitoring requirements. Part I is dedicated to an overall review of the principles of moderate sedation, Part II includes the American Society of Anesthesiology’s Practice Guidelines For Sedation And Analgesia by Non- Anesthesiologist. Part 3 is a post-test. Completion of this self-study packet includes learning the following material, satisfactory completion of the post-test and returning the post-test to the Medical Staff Office. Completion of this self-study is required to qualify for privileges to administer Moderate Sedation at St. David’s Medical Center. Purpose The purpose of this self-study packet is to increase and reinforce your knowledge of responsibilities and guidelines associated with the care of individuals requiring moderate sedation. On completion of this self-study program, you should be able to: 1. Recognize indications and contraindication for moderate sedation. 2. State appropriate monitoring techniques and requirements for patients undergoing moderate sedation. 3. Identify medications frequently used for moderate sedation, administration guidelines, and potential complications/side-effects. 4. Evaluate and manage expected and unexpected outcomes of moderate sedation Part I Definition Conscious Sedation more accurately termed Sedation/Analgesia or Moderate Sedation describes a state that allows patients to tolerate unpleasant procedures while maintaining adequate cardiorespiratory function and the ability to respond purposefully to verbal commands and tactile stimulation. -
Developing an Airway Management Bundle to Standardize Emergent
It Takes A Village: Developing an Airway Management Bundle to Standardize Emergent Intubation Processes in the Emergency Department James Sacca, MD, Daniel Casey Kim, MD, Dimitri Papanagnou, MD, MPH, EdD(c) Department of Emergency Medicine, Thomas Jefferson University Hospital 1. Crash Airway Pre-medicate: Glycopyrrolate: 0.2 mg RSI TIME OUT If patient arrives without airway device present Ondansetron: 4 mg Pre-oxygenate and prepare for immediate intubation Nebulized or atomized Lidocaine: Patient Name__________________________________ If patient arrives with supraglottic device present 4 ml of 4% or 8 ml of 2% Needs Assessment Strategy #2 TJUH AIRWAY BUNDLE Problem Definition If able to oxygenate and ventilate, delay intubation Sedation: Code status permits intubation: Y or N or Unknown If patient arrives with ETT present Ketamine: 1 mg/kg bolus NPO since__________________ Confirm ETT placement (see 5.) Consider paralytic once successful Unconscious, Consider visualization with laryngoscopy Allergies______________________________ or NKDA Unreactive, D. Delayed sequence intubation 2. RSI Patient delirious/agitated so can’t pre-oxygenate We performed a FMEA to uncover latent threats through in situ Height___________________ Near death? Pre-medicate: Mallampati score_____________ Pretreatment: Glycopyrrolate: 0.2 mg Yes No For reactive airway disease: Lidocaine 1.5 mg/kg IV Ondansetron: 4 mg [ ] dentures removed Yes Airway management is at the core of emergent patient care. Emergent 1 For cardiovascular disease: Fentanyl 3 mcg/kg Sedation: simulation, as well as real patient intubations. A in situ simulation of Crash airway Difficult airway? For elevated ICP: both of the above meds/doses Ketamine: 1.5 mg/kg IBW bolus Personnel Pre-oxygenate No Induction: Paralyze intubations in the Emergency Department (ED) at Thomas Jefferson 1. -
Post-Intubation Analgesia and Sedation
POST-INTUBATION ANALGESIA AND SEDATION August 2012 J Pelletier Intubated patients experience pain and anxiety Mechanical ventilation, endotracheal tube Blood draws, positioning, suctioning Surgical procedures, dressing changes Awareness during neuromuscular blockade Invasive catheters Loss of control Unrelieved pain and anxiety cause adverse effects Self-injury and removal of life-sustaining devices Increased endogenous catecholamines Sleep deprivation, anxiety, and delirium Impaired post-ICU psychological recovery Emotional and posttraumatic effects Ventilator dysynchrony Immunosuppression Treating pain and anxiety improves outcomes Use of pain and sedation scales in critically ill patients allows: precise dosing reduced medication side effects reduced ICU and hospital length of stay shorter duration of mechanical ventilation Analgesics should be provided first, then anxiolysis If you were intubated, how much lorazepam or midazolam, and fentanyl would you want per hour? Intubated ED patients receive inadequate analgesia and sedation Retrospective study, tertiary ED 50% received no analgesia, 30% received no anxiolytic Of patients receiving postintubation vecuronium, 96% received either no or inadequate anxiolysis or analgesia Overall, 3 of 4 patients received no or inadequate analgesia and an equivalent number received no or inadequate anxiolysis Bonomo 2007 Analgesia: opioids Bind CNS and peripheral tissue receptors Mu-1 receptors: analgesia Mu-2 receptors: respiratory depression, vomiting, constipation, and -
Brevital Sodium Methohexital Sodium for Injection
BREVITAL® SODIUM METHOHEXITAL SODIUM FOR INJECTION, USP For Intravenous Use in Adults For Rectal and Intramuscular Use Only in Pediatric Patients WARNING Brevital should be used only in hospital or ambulatory care settings that provide for continuous monitoring of respiratory (e.g. pulse oximetry) and cardiac function. Immediate availability of resuscitative drugs and age- and size-appropriate equipment for bag/valve/mask ventilation and intubation and personnel trained in their use and skilled in airway management should be assured. For deeply sedated patients, a designated individual other than the practitioner performing the procedure should be present to continuously monitor the patient. (See WARNINGS) DESCRIPTION Brevital® Sodium (Methohexital Sodium for Injection, USP) is 2,4,6 (1H, 3H, 5H)- Pyrimidinetrione, 1-methyl-5-(1-methyl-2-pentynyl)-5-(2-propenyl)-, (±)-, monosodium salt and has the empirical formula C14H17N2NaO3. Its molecular weight is 284.29. The structural formula is as follows: Methohexital sodium is a rapid, ultrashort-acting barbiturate anesthetic. Methohexital sodium for injection is a freeze-dried, sterile, nonpyrogenic mixture of methohexital sodium with 6% anhydrous sodium carbonate added as a buffer. It contains not less than 90% and not more than 110% of the labeled amount of methohexital sodium. It occurs as a white, freeze-dried plug that is freely soluble in water. This product is oxygen sensitive. The pH of the 1% solution is between 10 and 11; the pH of the 0.2% solution in 5% dextrose is between 9.5 and 10.5. Methohexital sodium may be administered by direct intravenous injection or continuous intravenous drip, intramuscular or rectal routes (see PRECAUTIONS—Pediatric Use). -
The Waterloo Wellington Palliative Sedation Protocol
The Waterloo Wellington Palliative Sedation Protocol Waterloo Wellington Interdisciplinary HPC Education Committee; PST Task Force Chair: Dr. Deborah Robinson MD CCFP(F), Focused practice in Oncology and Palliative Care Co-chairs: Cathy Joy, Palliative Care Consultant, Waterloo Region Chris Bigelow, Palliative Care Consultant, Wellington County Revision due: November 2016 Last revised and activated: November 13, 2013 Committee responsible for revisions: WW Interdisciplinary HPC Education Committee Table of Contents Purpose and Definitions .................................................................................................................... 2 Indications for the use of PST .............................................................................................................. 3 Criteria for Initiation of PST ............................................................................................................... 4 Process ............................................................................................................................................. 4 Documentation for Initiation of PST .................................................................................................. 5 Medications ......................................................................................................................................... 6 1st Line (Initiating PST) ...................................................................................................................... 6 2nd Line (When 1st